FDA Eliminates Animal Testing: Impact on Biotechs
The Premier Consulting Blog
APRIL 13, 2025
On April 10, 2025, the US FDA announced that it has a long-term plan to eliminate conventional animal testing in drug development, starting with monoclonal antibodies (mAbs).[ 2] An overview of the 3Rs The FDA and other global regulatory health authorities have long embraced the 3Rs of animal research (replace, reduce, and refine).
Let's personalize your content